← Leaderboards
Jason Matthew Zand
Surgisense Corporation
$4,144,875
Attributed
$4,144,875
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2009–16$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$4,144,875 · 4
By mechanism
R44$3,716,989 · 2
R43$427,886 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Colorectal Cancer”
- Norman Wolmark · Nsabp Foundation, Inc.$253,344,814
- Joseph P. Costantino · University Of Pittsburgh At Pittsburgh$72,920,401
- William J. Blot · Vanderbilt University$60,929,890
- Loic Le Marchand · University Of Hawaii At Manoa$57,327,999
- Ulrike Peters · Fred Hutchinson Cancer Research Center$56,201,247
- Andrew T Chan · Massachusetts General Hospital$47,099,005
Research focus
Colorectal CancerBaseCessation Of LifeDevicesDesignTissuesModalityPerformanceExcisionProceduresOxygenIntestinesAnimalsFamily SuidaeSideInstrumentTissue OxygenationMonitorIn VivoColonSeriesAnteriorHealth Care CostsAnimal Model
Grant awards (6)
Oxygen Mapping System for Enhanced Colonoscopic Neoplasm Detection$927,780
R44 · FY2016 · CA · contact PI
Oxygen Mapping System for Enhanced Colonoscopic Neoplasm Detection$1,072,220
R44 · FY2015 · CA · contact PI
Device to Improve Treatment of Colorectal CA using O2 Dependent Phosphorescence$837,727
R44 · FY2013 · CA · contact PI
Device to Improve Treatment of Colorectal CA using O2 Dependent Phosphorescence$879,262
R44 · FY2012 · CA · contact PI
Device to Improve Treatment of Colorectal Cancer Using O2 Dependent Phosphorescen$228,501
R43 · FY2010 · CA · contact PI
A Device to Reduce Anastomotic Failure in the Treatment of Colorectal Cancer$199,385
R43 · FY2009 · CA · contact PI